Novolin n and Impaired gastric emptying - a phase IV clinical study of FDA data

Summary:

Impaired gastric emptying is found among people who take Novolin n, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Novolin n and have Impaired gastric emptying. It is created by eHealthMe based on reports of 2,364 people who have side effects when taking Novolin n from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 18, 2023

2,364 people reported to have side effects when taking Novolin n.
Among them, 6 people (0.25%) have Impaired gastric emptying.

What is Novolin n?

Novolin n has active ingredients of insulin susp isophane semisynthetic purified human. It is often used in diabetes. eHealthMe is studying from 2,201 Novolin n users for its effectiveness, alternative drugs and more.

What is Impaired gastric emptying?

Impaired gastric emptying is found to be associated with 1,764 drugs and 775 conditions by eHealthMe.

Number of Novolin n and Impaired gastric emptying reports submitted per year:

Could Novolin n cause Impaired gastric emptying?

Gender of people who have Impaired gastric emptying when taking Novolin n *:

female: 50 %
male: 50 %

Age of people who have Impaired gastric emptying when taking Novolin n *:

Common drugs people take besides Novolin n *:

Common side effects people have besides Impaired gastric emptying *:

Nausea And Vomiting: 2 people, 33.33%
Dehydration (dryness resulting from the removal of water): 2 people, 33.33%
Pneumonia: 2 people, 33.33%
Blood Glucose Increased: 2 people, 33.33%
Blood Glucose Decreased: 2 people, 33.33%
Nausea (feeling of having an urge to vomit): 2 people, 33.33%
Weight Increased: 1 person, 16.67%
Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 16.67%
Drug Hypersensitivity: 1 person, 16.67%
Dizziness: 1 person, 16.67%

Common conditions people have *:

Pain: 2 people, 33.33%
High Blood Pressure: 2 people, 33.33%
Type 2 Diabetes: 1 person, 16.67%
Tinnitus (a ringing in the ears): 1 person, 16.67%
Spinal Column Stenosis (narrowing of spinal column): 1 person, 16.67%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 16.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 16.67%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 16.67%
Parkinson's Disease: 1 person, 16.67%
Neuralgia (pain in one or more nerves): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Novolin n and have Impaired gastric emptying?

Check whether Impaired gastric emptying is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Impaired gastric emptying and when was it recovered:

Impaired gastric emptying in Novolin n

Expand to all the drugs that have ingredients of insulin susp isophane semisynthetic purified human:

Impaired gastric emptying and drugs with ingredients of insulin susp isophane semisynthetic purified human (8 reports)

Alternative drugs to, pros and cons of Novolin n:

Novolin n (2,201 reports)

Common Novolin n side effects:

Drug ineffective: 152 reports

Browse all side effects of Novolin n:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Impaired gastric emptying treatments and more:

Impaired gastric emptying (10,417 reports)

COVID vaccines that are related to Impaired gastric emptying:

Common drugs associated with Impaired gastric emptying:

How the study uses the data?

The study uses data from the FDA. It is based on insulin susp isophane semisynthetic purified human (the active ingredients of Novolin n) and Novolin n (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.